C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2004
11/16/2004	US6818398 Column device for isolation and labeling of nucleic acids
11/16/2004	US6818394 High density immobilization of nucleic acids
11/16/2004	US6818392 Monoclonal antibodies to human immunodeficiency virus and uses thereof
11/16/2004	US6818220 Vascular endothelial growth factor C (VEGF-C) protein and gene mutants thereof, and uses thereof
11/16/2004	US6818215 Antibodies to senescent cell-derived inhibiters of DNA synthesis
11/16/2004	US6818214 Modulating cell proliferation or apoptosis comprising modulating psoriastatin activity
11/16/2004	US6818210 Introducing non-tumorogenic skeletal myoblasts or cardiomyocytes in myocardial tissue of the animal so as to form a stable myocardial graft, can be used, to deliver recombinant proteins directly to the heart
11/16/2004	US6818209 Capable of transducing target cells; includes nucleotide sequence encoding at least part of rabies g protein material
11/16/2004	CA2525291A1 P. aeruginosa mucoid exopolysaccharide specific binding peptides
11/16/2004	CA2159109C Therapeutic uses of keratinocyte growth factor
11/16/2004	CA2136618C Expression of genes in transgenic plants
11/16/2004	CA2120342C Epstein-barr virus peptides and antibodies against these peptides
11/16/2004	CA2074719C Calcium channel compositions and methods
11/11/2004	WO2004097530A1 Structure and method for producing structure, toner containing structure, image forming method and device using toner
11/11/2004	WO2004097416A1 Magnetic substance-biosubstance complex structure, peptide fragment capable of linking to magnetic substance and gene therefor, and process for structure
11/11/2004	WO2004097049A1 Oligoribonucleotides and ribonucleases for cleaving rna
11/11/2004	WO2004097047A1 Mutations in the human pcsk9 gene associated to hypercholesterolemia
11/11/2004	WO2004097042A1 Sirna selection method
11/11/2004	WO2004097027A2 Screening of biocatalysts in plants
11/11/2004	WO2004097025A2 A method of transducing neural stem cells bound to a fibronectin fragment
11/11/2004	WO2004097024A1 Tissue specific promoters
11/11/2004	WO2004097023A1 Plants with pathogen resistance
11/11/2004	WO2004097022A1 Catalyst for sugar chain cleavage
11/11/2004	WO2004097021A1 Nucleic acid detection
11/11/2004	WO2004097020A2 Rna interference mediated inhibition of map kinase gene expression
11/11/2004	WO2004097017A2 Compositions for enhancing transport and antisense efficacy of nucleic acid analog into cells
11/11/2004	WO2004097016A1 Adenovirus serotype 34 vectors, nucleic acids and virus produced thereby
11/11/2004	WO2004097015A1 Array having substances fixed on support arranged with chromosomal order or sequence position information added thereto, process for producing the same, analytical system using the array and use of these
11/11/2004	WO2004097013A1 Gdc-1 genes conferring herbicide resistance
11/11/2004	WO2004097004A2 Trasngenic expression of a phytochrome a gene
11/11/2004	WO2004096999A2 In vitro translation system
11/11/2004	WO2004096996A2 Modulation of glucagon receptor expression
11/11/2004	WO2004096994A2 Genes upregulated in a tomato plant having an increased anthocyanin content phenotype
11/11/2004	WO2004096993A2 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
11/11/2004	WO2004096987A2 A forward mutation assay based on 5-fluorouracil resistance
11/11/2004	WO2004096984A2 Preservation of rna in a biological sample
11/11/2004	WO2004096978A2 Production of high mannose proteins in plant culture
11/11/2004	WO2004096976A2 Spex compositions and methods of use
11/11/2004	WO2004096892A1 Functional polymer having function of trapping substance, reagent kit for substance trapping including the polymer, and method of recovering substance with the polymer
11/11/2004	WO2004096861A1 Method for modifying the size and/or morphology of starch granules
11/11/2004	WO2004096860A1 Method of producing target protein, fused protein and gene thereof, partial sequence protein of intein and gene thereof, expression vector and transformant
11/11/2004	WO2004096859A1 Chaperonine-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure of target protein, sustained-release preparation and method of producing antibody against target protein
11/11/2004	WO2004096852A1 A RECOMBINANT HUMAN INTERFERON ϖ, THE METHOD FOR EXPRESSING IT AND THE USES OF IT
11/11/2004	WO2004096850A1 Method for the production of an n-terminally modified chemotactic factor
11/11/2004	WO2004096846A2 Nogo-b, a regulator of endothelial cell function and vessel remodeling
11/11/2004	WO2004096844A2 Group 1 mite polypeptide variants
11/11/2004	WO2004096843A1 Polypeptide capable of assisting digestive organ absorption
11/11/2004	WO2004096832A2 Novel antiangiogenic peptides
11/11/2004	WO2004096827A2 Plant retroelements and methods related thereto
11/11/2004	WO2004096826A2 Method for selective inhibition of human n-myc gene in n-myc expressing tumors through antisense and antigen peptido-nucleic acids (pna)
11/11/2004	WO2004096289A1 Gene introduction efficiency enhancer
11/11/2004	WO2004096288A2 Method of obtaining dna replication minicircles which are intended to be used for gene transfer or as immunomodulators
11/11/2004	WO2004096277A1 Preventive or therapeutic agent for intraocular vascularization disease
11/11/2004	WO2004096257A2 Genetic modification of targeted regions of the cardiac conduction system
11/11/2004	WO2004096253A1 Use of inhibitors and antisense oligonucleotides of btk for treating proliferative mastocytosis
11/11/2004	WO2004096188A1 Polyhydroxyalkanoate-containing magnetic structure, and manufacturing method and use thereof
11/11/2004	WO2004096142A2 Alk protein tyrosine kinase, cells and methods embodying and using same
11/11/2004	WO2004096140A2 Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
11/11/2004	WO2004096136A2 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof
11/11/2004	WO2004096124A2 Compositions and methods for the diagnosis and treatment of tumor
11/11/2004	WO2004096016A2 Modulation of glucagon receptor expression
11/11/2004	WO2004085656A3 Enhanced accumulation of carotenoids in plants
11/11/2004	WO2004084831A3 Optimized expression of hpv 31 l1 in yeast
11/11/2004	WO2004083430A3 SHORT INTERFERING RNA (siRNA) ANALOGUES
11/11/2004	WO2004083391A3 Targeted and regional cellular ablation in zebrafish
11/11/2004	WO2004080202A3 Production of plants with improved digestibility having an inactive peroxidase
11/11/2004	WO2004079332A3 Composition and method for increasing efficiency of introduction of target substance into cell
11/11/2004	WO2004078713A3 Morpholino based activity mapping
11/11/2004	WO2004070020A3 Glyphosate tolerant alfalfa events and methods for detection thereof
11/11/2004	WO2004070005A3 Double ended sequencing
11/11/2004	WO2004069858A3 Leukocyte stimulating peptides
11/11/2004	WO2004066949A8 Antisense oligonucleotides that inhibit expression of hif-1
11/11/2004	WO2004065558A8 Depletion of endogenous primordial germ cells in avian species
11/11/2004	WO2004064773A3 Inhibition of e3-ubiquitin ligase hakai for treatment of proliferative disorders
11/11/2004	WO2004063349A3 Lysozyme transgenic ungulates
11/11/2004	WO2004061119A3 Rolling circle amplification of rna
11/11/2004	WO2004058801A3 Modified vaccinia ankara expressing p53 in cancer immunotherapy
11/11/2004	WO2004058179A3 Immunostimulatory sequence oligonucleotides and methods of using the same
11/11/2004	WO2004054508A3 Immunogenic compositions including rough phenotype brucella host strains and complementation dna fragments
11/11/2004	WO2004048583A3 Compositions and systems for the regulation of genes
11/11/2004	WO2004048410A3 T-cell receptors
11/11/2004	WO2004044143A3 Tps plant gene constructs and transformants
11/11/2004	WO2004042024B1 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF HIF-1 ALPHA
11/11/2004	WO2004033421A3 Improved production of bacterial strains
11/11/2004	WO2004027384A3 Real-time detection of nucleic acid reactions
11/11/2004	WO2004026907A3 Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals
11/11/2004	WO2004024941A3 Biochemical methods for measuring metabolic fitness of tissues or whole organisms
11/11/2004	WO2004024872A3 Method for expression of small antiviral rna molecules within a cell
11/11/2004	WO2004022586A3 Tubulysin biosynthesis gene
11/11/2004	WO2004020404A3 Modified transferin-antibody fusion proteins
11/11/2004	WO2004015070A3 Isolation and identification of t cells
11/11/2004	WO2004011625A3 Polymorphisms for predicting disease and treatment outcome
11/11/2004	WO2004010935A3 Methods of treating and preventing rsv, hmpv, and piv using anti-rsv, anti-hmpv, and anti-piv antibodies
11/11/2004	WO2004009799A3 Ion channel receptor and uses thereof
11/11/2004	WO2004009775A3 Methods and compositions relating to chimeric nicotinic receptor subunits
11/11/2004	WO2003104397A3 Antisense modulation of g protein-coupled receptor kinase 6 expression
11/11/2004	WO2003102166A8 Novel flavivirus antigens
11/11/2004	WO2003101394A3 Defensins: use as antiviral agents
11/11/2004	WO2003088916A3 Compositions and methods for the acceleration of protein secretion dynamics
11/11/2004	WO2003087411A8 Method to inhibit cell growth using oligonucleotides

1 ... 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 ... 4023